
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Vogenx (NASDAQ:VOGX) through any online brokerage.
Other companies in Vogenx’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Vogenx has a consensus price target of $48.50.
The stock price for Vogenx (NASDAQ: VOGX) is $14.98 last updated October 7, 2026 at 1:32 PM EDT.
There are no upcoming dividends for Vogenx.
Vogenx does not have any upcoming earnings scheduled.
There is no upcoming split for Vogenx.
Vogenx is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Vogenx Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies for the treatment of serious diseases associated with dysfunctions in human metabolism, including post-bariatric hypoglycemia, or...